Human TLR10 is an anti-inflammatory pattern-recognition receptor

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 42, 2014, Pages E4478-E4484

  Oosting, Marije ^a   Cheng, Shih Chin ^a   Bolscher, Judith M ^b   Vestering Stenger, Rachel ^a   Plantinga, Theo S ^a   Verschueren, Ineke C ^a   Arts, Peer ^a   Garritsen, Anja ^b   Van Eenennaam, Hans ^b   Sturm, Patrick ^a   Kullberg, Bart Jan ^a   Hoischen, Alexander ^a   Adema, Gosse J ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^a   Joosten, Leo A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cytokines; Immunology; SNPs; TLR10

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; TLR10 PROTEIN, HUMAN; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR;

ANIMAL; C57BL MOUSE; CYTOLOGY; GENETIC POLYMORPHISM; HEK293 CELL LINE; HUMAN; INFLAMMATION; MALE; METABOLISM; MONONUCLEAR CELL; MOUSE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; CYTOKINES; HEK293 CELLS; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, PATTERN RECOGNITION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 10; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84908045947     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1410293111     Document Type: Article

References (24)

1. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499-511.
2. Chuang T, Ulevitch RJ (2001) Identification of hTLR10: A novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 1518(1-2):157-161.
3. Hasan U, et al. (2005) Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174(5):2942-2950.
4. Guan Y, et al. (2010) Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J Immunol 184(9):5094-5103.
5. Hornung V, et al. (2002) Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168(9):4531-4537.
6. Nagase H, et al. (2003) Expression and function of Toll-like receptors in eosinophils: Activation by Toll-like receptor 7 ligand. J Immunol 171(8):3977-3982.
7. Mulla MJ, et al. (2012) Cutting-edge report: TLR10 plays a role in mediating bacterial peptidoglycan-induced trophoblast apoptosis. Am J Reprod Immunol 69(5):449-453.
8. Godfroy JI, 3rd, Roostan M, Moroz YS, Korendovych IV, Yin H (2012) Isolated Toll-like receptor transmembrane domains are capable of oligomerization. PLoS ONE 7(11):e48875.
9. Hirschfeld M, et al. (1999) Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J Immunol 163(5):2382-2386.
10. Oosting M, et al. (2011) TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. PLoS ONE 6(10):e25998.
11. Barreiro LB, et al. (2009) Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5(7):e1000562.
12. Stevens VL, et al. (2008) Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer 123(11):2644-2650.
13. Requena T, et al. (2013) Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease. Immunogenetics 65(5):345-355.
14. Mikacenic C, Reiner AP, Holden TD, Nickerson DA, Wurfel MM (2013) Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes Immun 14(1):52-57.
15. Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11(8):633-652.
16. Dinarello CA (2005) Blocking IL-1 in systemic inflammation. J Exp Med 201(9):1355-1359.
17. Brandt KJ, Carpintero R, Gruaz L, Molnarfi N, Burger D (2010) A novel MEK2/PI3Kδ pathway controls the expression of IL-1 receptor antagonist in IFN-β-activated human monocytes. J Leukoc Biol 88(6):1191-1200.
18. Molnarfi N, Hyka-Nouspikel N, Gruaz L, Dayer JM, Burger D (2005) The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1. J Immunol 174(5):2974-2980.
19. Regan T, et al. (2013) Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol 191(12):6084-6092.
20. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G (2001) Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor. J Immunol 166(12):7477-7485.
21. Geijtenbeek TB, et al. (2003) Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197(1):7-17.
22. Oosting M, et al. (2010) Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis 201(12):1849-1858.
23. Hirschfeld M, et al. (2001) Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69(3):1477-1482.
24. van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ (2005) Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun 73(11):7458-7464.